Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.

Vérin M, Sesar Á, Amlani B, Smith N, Kipentzoglou K, Montgomery S, Reading A, Karlsson A, Willis A, Lees AJ

Open source

DOI
10.1007/s40120-025-00789-9
Published
2025 Oct
Container
Neurology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-025-00789-9,
  title = {Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.},
  author = {Vérin M and Sesar Á and Amlani B and Smith N and Kipentzoglou K and Montgomery S and Reading A and Karlsson A and Willis A and Lees AJ},
  year = {2025},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-025-00789-9},
  url = {https://doi.org/10.1007/s40120-025-00789-9}
}

RIS

TY  - JOUR
TI  - Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.
AU  - Vérin M
AU  - Sesar Á
AU  - Amlani B
AU  - Smith N
AU  - Kipentzoglou K
AU  - Montgomery S
AU  - Reading A
AU  - Karlsson A
AU  - Willis A
AU  - Lees AJ
PY  - 2025
JO  - Neurology and therapy
DO  - 10.1007/s40120-025-00789-9
UR  - https://doi.org/10.1007/s40120-025-00789-9
ER  - 

APA

M, V., Á, S., B, A., N, S., K, K., S, M., A, R., A, K., A, W., & AJ, L. (2025). Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.. Neurology and therapy. https://doi.org/10.1007/s40120-025-00789-9

Source records